UK markets closed

MiMedx Group, Inc. (MDXG)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.37-0.13 (-1.73%)
At close: 04:00PM EDT
7.37 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.09B
Enterprise value 1.06B
Trailing P/E 14.17
Forward P/E 19.92
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.41
Price/book (mrq)6.99
Enterprise value/revenue 3.17
Enterprise value/EBITDA 19.68

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 328.87%
S&P500 52-week change 322.38%
52-week high 39.27
52-week low 35.47
50-day moving average 37.37
200-day moving average 37.53

Share statistics

Avg vol (3-month) 3872.01k
Avg vol (10-day) 31.03M
Shares outstanding 5147.6M
Implied shares outstanding 6150.21M
Float 8117.63M
% held by insiders 12.24%
% held by institutions 161.17%
Shares short (15 Apr 2024) 45.51M
Short ratio (15 Apr 2024) 46.16
Short % of float (15 Apr 2024) 44.66%
Short % of shares outstanding (15 Apr 2024) 43.73%
Shares short (prior month 15 Mar 2024) 45.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23235:10000
Last split date 302 Apr 2008

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 21.67%
Operating margin (ttm)15.64%

Management effectiveness

Return on assets (ttm)16.26%
Return on equity (ttm)68.13%

Income statement

Revenue (ttm)334.51M
Revenue per share (ttm)2.69
Quarterly revenue growth (yoy)18.20%
Gross profit (ttm)N/A
EBITDA 53.98M
Net income avi to common (ttm)68.48M
Diluted EPS (ttm)0.52
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)48.49M
Total cash per share (mrq)0.33
Total debt (mrq)19.45M
Total debt/equity (mrq)12.49%
Current ratio (mrq)3.29
Book value per share (mrq)1.06

Cash flow statement

Operating cash flow (ttm)36.8M
Levered free cash flow (ttm)28.37M